Implications of mismatch repair genes hMLH1 and hMSH2 in patients with sporadic renal cell carcinoma

BJU International

Volumn 102, Issue 4, 2008, Pages 504-509

  Rubio Del Campo, Antonio ^a   Salinas Sánchez, Antonio S ^a,c   Sánchez Sánchez, Francisco ^b   Giménez Bachs, José M ^a   Donate Moreno, María J ^a   Pastor Navarro, Héctor ^a   Carrión López, Pedro ^a   Escribano, Julio ^b  

^a Hospital and University Complex   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c NONE   (Spain)

Author keywords

DNA methylation; DNA mismatch repair genes; Loss of heterozygosity; Microsatellite instability; RCC

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DNA METHYLATION; DNA MISMATCH REPAIR; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION;

EID: 47749092489     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07581.x     Document Type: Article

References (30)

1. Long JP, Anglard P, Gnarra JR et al. The use of molecular genetic analysis in the diagnosis of renal cell carcinoma. World J Urol 1994 12 : 69 73
2. Alimov A, Kost-Alimova M, Liu J et al. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 2000 19 : 1392 9
3. Willers CP, Siebert R, Bardenheuer W et al. Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinoma. Br J Urol 1996 77 : 524 9
4. Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 1995 273 : 564 70
5. Liu B, Parsons R, Papadopoulos N et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996 2 : 169 74
6. Frayling IM. Microsatellite instability. Gut 1999 45 : 1 4
7. Perucho M. Cancer of the microsatellite mutator phenotype. Biol Chem 1996 377 : 675 84
8. Streisinger G, Okada Y, Emrich J et al. Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold Spring Harb Symp Quant Biol 1966 31 : 77 84
9. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993 260 : 816 9
10. Samowitz WS, Curtin K, Neuhausen S, Schaffer D, Slattery ML. Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability. Genes Chromosom Cancer 2002 35 : 368 71
11. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999 81 : 214 8
12. Hartmann A, Cheville JC, Dietmaier W, Hofstadter F, Burgart LJ, Blaszyk H. Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Arch Pathol Lab Med 2003 127 : E60 3
13. Roupret M, Fromont G, Azzouzi AR et al. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 2005 65 : 1233 7
14. Catto JW, Xinarianos G, Burton JL, Meuth M, Hamdy FC. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 2003 105 : 484 90
15. Chen HC, Bhattacharyya N, Wang L et al. Defective DNA repair genes in a primary culture of human renal cell carcinoma. J Cancer Res Clin Oncol 2000 126 : 185 90
16. Deguchi M, Shiina H, Igawa M, Kaneuchi M, Nakajima K, Dahiya R. DNA mismatch repair genes in renal cell carcinoma. J Urol 2003 169 : 2365 71
17. Arai E, Kanai Y, Ushijima S, Fujimoto H, Mukai K, Hiroshashi S. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int J Cancer 2006 119 : 288 96
18. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998 58 : 5248 57
19. Gonzalgo ML, Eisenberger CF, Lee SM et al. Prognostic significance of preoperative molecular serum analysis in renal cancer. Clin Cancer Res 2002 8 : 1878 81
20. Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 1995 55 : 6189 95
21. Dulaimi E, Ibanez de Caceres I, Uzzo RG et al. Promoter hypermethylation profile of kidney cancer. Clin Cancer Res 2004 10 : 3972 9
22. Leach F, Koh M, Sharma K et al. Mismatch repair gene mutations in renal cell carcinoma. Cancer Biol Ther 2002 1 : 530 6
23. Shin KH, Ku JL, Kim WH et al. Establishment and characterization of seven human renal cell carcinoma cell lines. BJU Int 2000 85 : 130 8
24. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002 156 : 885 902
25. Raevaara TE, Korhonen MK, Lohi H et al. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 2005 129 : 537 49
26. Caldes T, Godino J, de la Hoya M et al. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer 2002 98 : 774 9
27. Brieger A, Trojan J, Raedle J, Plotz G, Zeuzem S. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants. Gut 2002 51 : 677 84
28. Liu T, Stathopoulos P, Lindblom P et al. MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility. Eur J Cancer 1998 34 : 1981
29. Pinol V, Castells A, Andreu M et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005 293 : 1986 94
30. Domingo E, Laiho P, Ollikainen M et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004 41 : 664 8